367 related articles for article (PubMed ID: 22389029)
21. [The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
Wang YK; Shen L; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):514-517. PubMed ID: 28728297
[No Abstract] [Full Text] [Related]
22. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer.
Hirajima S; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Ikoma H; Otsuji E
World J Gastroenterol; 2013 Sep; 19(36):6055-61. PubMed ID: 24106406
[TBL] [Abstract][Full Text] [Related]
23. Hepatoid adenocarcinoma of the stomach: a case report.
Sugawara Y; Konishi T; Hiraishi M; Sato A; Natomi H; Aoki T; Makuuchi M
Hepatogastroenterology; 1996; 43(10):995-9. PubMed ID: 8884327
[TBL] [Abstract][Full Text] [Related]
24. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Ishigami S; Natsugoe S; Nakashima H; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Nakashima S; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(69):338-41. PubMed ID: 16795967
[TBL] [Abstract][Full Text] [Related]
25. [The characters of AFP-producing early gastric cancer].
Chang YC; Nagasue N; Abe S; Kohno H; Yamanoi A; Uchida M; Nakamura T
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1574-80. PubMed ID: 1702182
[TBL] [Abstract][Full Text] [Related]
26. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological study of AFP producing gastric cancer--significance of AFP in gastric cancer].
Takahashi Y; Mai M; Ogino T; Ueda H; Sawaguchi K; Ueno M
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):696-700. PubMed ID: 2442592
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
29. [Hepatoid adenocarcinoma of the stomach. A case report].
Jalle T; Gérard C; Lada PE; Sagan C; Gournay J; Arnaud JP; Paineau J; Hamy A
Ann Chir; 2006 Mar; 131(3):213-5. PubMed ID: 16293220
[TBL] [Abstract][Full Text] [Related]
30. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features of the patients with node-negative metastasis gastric adenocarcinoma and their survival analysis].
Li J; Cai SR; He YL; Huang MJ; Mei KY; Wang JP; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):230-3. PubMed ID: 16721684
[TBL] [Abstract][Full Text] [Related]
32. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
Kang GH; Kim YI
Virchows Arch; 1998 Jan; 432(1):85-7. PubMed ID: 9463592
[TBL] [Abstract][Full Text] [Related]
33. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
Kochi M; Fujii M; Kaiga T; Takahashi T; Morishita Y; Kobayashi M; Kasakura Y; Takayama T
Oncology; 2004; 66(6):445-9. PubMed ID: 15452373
[TBL] [Abstract][Full Text] [Related]
34. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
36. [Hepatoid adenocarcinoma of the stomach].
Votte A; Sevestre H; Dupas JL; Joly JP; Bental A; Delamarre J; Capron JP
Gastroenterol Clin Biol; 1991; 15(5):437-40. PubMed ID: 1712742
[TBL] [Abstract][Full Text] [Related]
37. Hepatoid adenocarcinoma of the stomach - a rare pathological entity.
Muralee M; Ahamed I; Somanathan T; Anila KS
Gulf J Oncolog; 2011 Jan; (9):78-81. PubMed ID: 21177215
[TBL] [Abstract][Full Text] [Related]
38. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
40. [A case of AFP-producing gastric cancer accompanied with testicular tumor].
Watanabe M; Hamada Y; Matsushima T; Miyazaki T; Katoh H; Kawamura A; Fujita M; Sano K
Gan No Rinsho; 1988 Dec; 34(15):2131-7. PubMed ID: 2466135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
